Article Text


TLR3-mediated induction of Ro/SSA and La/SSB mRNA expression in salivary gland epithelial cells
  1. Nikolaos C Kyriakidis,
  2. Efstathia K Kapsogeorgou,
  3. Vasiliki C Gourzi,
  4. Menelaos N Manoussakis,
  5. Haralampos M Moutsopoulos,
  6. Athanasios G Tzioufas
  1. Department of Pathophysiology, School of Medicine, National University of Athens, Athens, Greece


Background-objectives In-situ over-expression of Ro/SSA (Ro52/TRIM21 and Ro60/TROVE2) and La/SSB mRNAs has been previously described in the salivary gland epithelial cells (SGEC) of Sjögren's syndrome (SS) patients. Recently, Ro52/TRIM21 has been shown to possess a regulatory role in TLR3-mediated inflammatory autoimmune responses. Herein, the authors examined whether TLR3 stimulation is implicated in the regulation of Ro52/TRIM21, as well as of Ro60/TROVE2 and La/SSB mRNA expression by SGEC.

Materials-methods SGEC-lines from SS patients (n=5) and non-SS controls (n=8), were treated with the TLR3-ligand analogue polyinosinic:cytidylic acid (polyI:C, 5 µg/ml) and the TLR4-ligand lipopolysaccharide (LPS, 1 µg/ml, control TLR-treatment) for various time-points. The expression of Ro52/TRIM21, Ro60/TROVE2 and La/SSB mRNAs was analysed by real-time PCR at 0, 6, 12, 24 and 48 h of treatment. The results were normalised by the expression of the HPRT1 gene and calculated by the ΔΔCT method using HeLa as calibrator. Statistically significantly different mRNA expression was evaluated by non-parametric Mann–Whitney analysis.

Results The basal (constitutive) mRNA expression levels of Ro52/TRIM21, Ro60/TROVE2 and La/SSB molecules were similar between SGEC lines from SS patients and controls. La/SSB and Ro60/TROVE2 mRNA levels were significantly upregulated following treatment of SGECs with polyI:C for 48 h (mean fold induction±SE: 1.87±0.19 and 2.38±0.31, respectively; p=0.004 each). PolyI:C was found to be a strong inducer of Ro52/TRIM21 mRNA expression by SGECs at 6 h of treatment (mean fold induction of basal expression±SE: 14.13±4.8, p<0.0001). The polyI:C induced Ro52/TRIM21 mRNA expression remained stable until 12 h of treatment, whereas a further increment was observed at 48 h of treatment (mean fold induction: 33.4±9.8 compared to basal levels). SGECs obtained from SS patients and controls were found to respond similarly to TLR3 signaling. LPS treatment was not found to affect either Ro/SSA (Ro52/TRIM21 or Ro60/TROVE2) or La/SSB mRNA expression.

Conclusion Our findings suggest that TLR3 signaling is implicated in Ro/SSA, and particularly, in Ro52/TRIM21 mRNA expression by SGECs. Further investigation is needed to clarify the mechanisms involved in this regulation.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.